{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:07:54Z","timestamp":1778861274400,"version":"3.51.4"},"reference-count":24,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"abstract":"<jats:p>ABSTRACT Fungemia caused by rare fungal species has been increasingly recognized in both immunocompromised and immunocompetent children. Our aim is to characterize the clinical and microbiological features of rare fungal bloodstream infections in hospitalized pediatric patients. A retrospective, descriptive study was conducted including all cases of fungemia due to rare yeasts in patients admitted to two tertiary pediatric hospitals between 2021 and 2025. Fungal species identification, anatomical sites of infection, antifungal therapeutic regimens, and clinical outcomes were systematically analyzed. In total, 13 cases of rare fungal bloodstream infections were identified among 13 patients from 2,555 blood cultures obtained during the study period, representing an incidence of 0.5%. The predominant species isolated were Saccharomyces cerevisiae (n=5), Wickerhamomyces anomalus (n=3), Candid orthopsilosis (n=2), Yarrowia lipolytica (n=1), Meyerozyma guilliermondii (n=1), and Trichosporon asahii (n=1). The median age at infection was 31 months (range: 0\u2013178 months), with 92.3% (12\/13) of patients presenting underlying medical conditions. The median interval from hospital admission to fungemia onset was 19 days (range: 0\u201373 days). Amphotericin B deoxycholate was the most frequently employed initial antifungal agent (n=5), followed by liposomal amphotericin B (n=4). Modification of antifungal therapy was required in five cases (38.5%). Microbiological clearance was achieved in all patients on subsequent blood cultures. The 30-day all-cause mortality rate was 15.4% (2\/13). We concluded that rare fungal bloodstream infections occurred predominantly in patients with underlying comorbidities and prolonged hospital stays; nevertheless, the majority showed favorable clinical responses with appropriate antifungal therapy and achieved fungal eradication from the bloodstream.<\/jats:p>","DOI":"10.1590\/s1678-9946202668034","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:12:42Z","timestamp":1778857962000},"source":"Crossref","is-referenced-by-count":0,"title":["Rare fungal bloodstream infections in pediatric patients: a case series"],"prefix":"10.1590","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6064-4014","authenticated-orcid":false,"given":"Nicole Feitosa Ximenes","family":"Ferreira","sequence":"first","affiliation":[{"name":"Universidade Federal Fluminense,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3992-7395","authenticated-orcid":false,"given":"Giovana Fernandes","family":"Zorzan","sequence":"additional","affiliation":[{"name":"Universidade Federal Fluminense,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3896-9226","authenticated-orcid":false,"given":"Andr\u00e9 Ricardo Ara\u00fajo da","family":"Silva","sequence":"additional","affiliation":[{"name":"Universidade Federal Fluminense,  Brazil; Comiss\u00e3o de Controle de Infec\u00e7\u00e3o Hospitalar,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2026]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1016\/S1473-3099(20)30784-2","article-title":"Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology","volume":"21","author":"Hoenigl M","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/myc.12792","article-title":"Candidemia in children: epidemiology, prevention and management","volume":"61","author":"Mantadakis E","year":"2018","journal-title":"Mycoses"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/1469-0691.12360","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections","volume":"20","author":"Arendrup MC","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e375","DOI":"10.1016\/S1473-3099(21)00203-6","article-title":"Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM","volume":"21","author":"Chen SC","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00064-23","article-title":"An update on clinically relevant, rare, and emerging Candida and Saccharomycotina yeasts that have been recently reclassified from Candida","volume":"38","author":"Francisco EC","year":"2025","journal-title":"Clin Microbiol Rev"},{"key":"ref6","series-title":"Nota T\u00e9cnica GVIMS\/GGTES\/DIRE3\/ANVISA N\u00ba 03\/2025: crit\u00e9rios diagn\u00f3sticos das infec\u00e7\u00f5es relacionadas \u00e0 assist\u00eancia \u00e0 sa\u00fade de notifica\u00e7\u00e3o nacional obrigat\u00f3ria: ano 2025"},{"key":"ref7","series-title":"Performance standards for antifungal susceptibility testing of yeasts: CLSI supplement M60","year":"2020","edition":"2nd ed."},{"key":"ref8","article-title":"Candida associated bloodstream infections in pediatric hematology patients: a single center experience","volume":"8","author":"Gokcebay DG","year":"2016","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/myc.12792","article-title":"Candidemia in children: epidemiology, prevention and management","volume":"61","author":"Mantadakis E","year":"2018","journal-title":"Mycoses"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12887-015-0354-3","article-title":"Trends in paediatric bloodstream infections at a South African referral hospital","volume":"15","author":"Dramowski A","year":"2015","journal-title":"BMC Pediatr"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/INF.0000000000001057","article-title":"Bloodstream infections in hospitalized children: epidemiology and antimicrobial susceptibilities","volume":"35","author":"Larru B","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"myae057","DOI":"10.1093\/mmy\/myae057","article-title":"Candida lusitaniae fungemia in children: a multicenter case series of emerging pathogen","volume":"62","author":"Snapiri O","year":"2024","journal-title":"Med Mycol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/08880018.2017.1316808","article-title":"Fatal course of Saprochaete capitata fungemia in children with acute lymphoblastic leukemia","volume":"34","author":"\u00d6zdemir ZC","year":"2017","journal-title":"Pediatr Hematol Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1097\/MPH.0000000000001420","article-title":"Chemoport-related fungemia caused by Trichosporon asahii","volume":"42","author":"Raju DS","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s101560170033","article-title":"Nosocomial fungemia due to amphotericin B-resistant Candida spp. in three pediatric patients after previous um neurosurgery for brain tumors","volume":"7","author":"Kovacicova G","year":"2001","journal-title":"J Infect Chemother"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1590\/s1678-9946202365012","article-title":"Saprochaete clavata invasive infection: characterization, antifungal susceptibility, and biofilm evaluation of a rare yeast isolated in Brazil","volume":"65","author":"Kraft L","year":"2023","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1111\/pde.13359","article-title":"Fatal disseminated Trichosporon asahii fungemia in a child with acute lymphoblastic leukemia and a morbilliform eruption","volume":"35","author":"Nguyen JK","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0255-0857(21)02477-4","article-title":"Fungemia caused by Verticillium species in an immunocompromised child","volume":"24","author":"Bashir G","year":"2006","journal-title":"Indian J Med Microbiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1128\/JCM.39.5.1702-1706.2001","article-title":"Outbreak of Pichia anomala infection in the pediatric service of a tertiary-care center in Northern India","volume":"39","author":"Chakrabarti A","year":"2001","journal-title":"J Clin Microbiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.24953\/turkjped.2010.1858","article-title":"Nosocomial transmission of Candida pelliculosa fungemia in a pediatric intensive care unit and review of the literature","volume":"52","author":"Kalkanci A","year":"2010","journal-title":"Turk J Pediatr"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jmii.2017.05.005","article-title":"Investigation of a nosocomial outbreak of fungemia caused by Candida pelliculosa (Pichia anomala) in a Korean tertiary care center","volume":"51","author":"Jung J","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.medmal.2013.06.008","article-title":"Septic\u00e9mie \u00e0 Saccharomyces cerevisiae chez un pr\u00e9matur\u00e9 trait\u00e9 par Ultra-Levure\u00ae","volume":"43","author":"Chioukh FZ","year":"2013","journal-title":"Med Mal Infect"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.24953\/turkjped.2020.1668","article-title":"Saccharomyces cerevisiae fungemia due to an unexpected source in the pediatric intensive care unit","volume":"64","author":"G\u00fcn E","year":"2022","journal-title":"Turk J Pediatr"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/myc.13297","article-title":"Fungaemia due to rare yeasts in paediatric intensive care units: a prospective study","volume":"64","author":"Kaur H","year":"2021","journal-title":"Mycoses"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0036-46652026000100219&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:12:45Z","timestamp":1778857965000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652026000100219&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":24,"alternative-id":["S0036-46652026000100219"],"URL":"https:\/\/doi.org\/10.1590\/s1678-9946202668034","relation":{},"ISSN":["1678-9946"],"issn-type":[{"value":"1678-9946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e34"}}